News Release

Horizon Pharma supports fellows and students with AGA Abstract Prizes

Grant and Award Announcement

American Gastroenterological Association

The American Gastroenterological Association (AGA) Research Foundation today announced Horizon Pharma's support of research awards aimed to stimulate interest in gastroenterology/hepatology research careers through competition and recognition:

  • AGA-Horizon Pharma Fellow Abstract Prizes provide three awards of $1,000 each to fellows who have submitted abstracts chosen to be presented during Digestive Disease Week® (DDW).
  • AGA-Horizon Pharma Student Abstract Prizes provide eleven travel awards of $500 each to high school, undergraduate, graduate and medical students who have submitted abstracts chosen by the AGA to be presented during DDW. Medical residents up to and including postgraduate year three are also eligible for the award. The three best student abstracts submitted will receive a $1,000 prize.

"We are extremely grateful to Horizon Pharma for their support of promising young researchers whose work could make a positive impact on the lives of patients," said Nicholas F. LaRusso, MD, AGAF, chair of the AGA Research Foundation. "This partnership with Horizon Pharma reinforces our belief that every individual donation makes a difference."

This year's fellow abstract prize recipients are:

  • Taeko Noah, PhD, Cincinnati Children's Medical Center, OH
  • Anne Peery, MD, University of North Carolina, Chapel Hill
  • Songhua Zhang, MD, PhD, Rhode Island Hospital, Alpert Medical School of Brown University, Providence

This year's student abstract prize recipients are:

  • Evelyn Covés-Datson, University of Michigan, Ann Arbor
  • Jessica Donnelly, University of Cincinnati, OH
  • Birgit Ey, Hospital of Essen/University of Duisburg, Germany
  • Yining Fu, University of Texas Southwestern Medical Center, Dallas
  • Victoria Gomez, Mayo Clinic, Jacksonville, FL
  • Suraj Gupta, MD, University of Michigan, Ann Arbor
  • Shabnam Khatami, MD, University of Texas Southwestern Medical Center, Dallas
  • Rachel Lees-Green, Mayo Clinic/University of Auckland, New Zealand
  • Stephanie Owyang, University of Michigan, Ann Arbor
  • Sunny Singh, MD, University of Manitoba, Edmonton, Alberta, Canada
  • Andrea Tyler, HBSc, Mt. Sinai Hospital/University of Toronto, Ontario, Canada

"We are proud to be working with the AGA Research Foundation to invest in the future of gastroenterology research by funding these grants," said Timothy P. Walbert, chairman, president and chief executive officer of Horizon Pharma. "We congratulate this year's recipients and look forward to seeing our grant recipients flourish in their careers."

###

About the AGA Research Foundation

The AGA Research Foundation, formerly known as the Foundation for Digestive Health and Nutrition, is the cornerstone of AGA's effort to expand digestive disease research funding. Since 1984, the AGA, through its foundations, has provided more than $40 million in research grants to more than 600 scientists. The AGA Research Foundation serves as a bridge to the future of research in gastroenterology and hepatology by providing critical funding to advance the careers of young researchers between the end of training and the establishment of credentials that earn National Institutes of Health grants. Learn more about the AGA Research Foundation or make a contribution at www.gastro.org/aga-foundation.

About the AGA Institute

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org.

Become an AGA fan on Facebook.
Join our LinkedIn group.
Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.

About Horizon Pharma

Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit www.horizonpharma.com.


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.